ClinicalTrials.gg
Not yet recruitingNCT07654153Updated Jul 21, 2026

Surgical Positions and Postoperative Atelectasis: A Lung Ultrasound Study

An observational study in Lung Ultrasound and Atelectasis, sponsored by Cumhuriyet University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-21.

Sponsored by Cumhuriyet University · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
100
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The aim of this study is to prospectively evaluate the effect of surgical position on the development of postoperative atelectasis in patients undergoing surgery in supine, prone, lateral decubitus, and lithotomy positions using lung ultrasonography (LUS), and to investigate whether there is a difference between these positions.

Read the detailed description

Study Groups: Patients will be divided into 4 groups according to the surgical position to be given during the operation:

  • Group 1 (Supine, n=25)
  • Group 2 (Prone, n=25)
  • Group 3 (Lateral Decubitus, n=25)
  • Group 4 (Lithotomy, n=25) All patients will receive standard anesthesia induction and maintenance with 1 mcg/kg fentanyl citrate, 2 mg/kg propofol, 0.6 mg/kg rocuronium intravenously, followed by maintenance with desfluran at a MAC of 0.8-1.2 (if necessary). Patient demographic data (age, gender, height, weight, BMI, ASA score, comorbidities) and intraoperative data (heart rate, SpO2, mean arterial pressure, duration of surgery, surgical position, applied PEEP level) will be recorded.

Lung Ultrasonography (LUS) Protocol: LUS evaluation, Dr. The ultrasound will be performed by Burak Ağar using a Mindray ultrasound device [Device brand/model and probe type, e.g., 3.5-5 MHz convex or 7-12 MHz linear probe]. LUS will be performed using a 12-zone protocol consisting of 6 standard zones (upper and lower quadrants of the anterior, lateral, and posterior regions) for both hemithoraxes. The evaluation will be performed at 3 different time points:

  1. Preoperative (T0): Immediately before anesthesia induction, in the supine position (Baseline).
  2. Postoperative (T1): Immediately before the patient is awakened, in the supine position.
  3. Postoperative (T2): 20 minutes after the patient is transferred to the PACU. MLUS Scoring: Each region will be scored between 0-3 according to lung ventilation (MLUS Score):

    • 0 Points: Normal ventilation (presence of A-line, fewer than 3 B-lines)
    • 1 Point: Minor ventilation loss (≥ 3 B-lines or subpleural consolidations ≤ 1 cm in diameter separated by a normal pleural line)
    • 2 Points: Moderate ventilation loss (Multiple small subpleural consolidations ≤ 1 cm in diameter separated by multiple and converging B-lines or a thickened/irregular pleural line)
    • 3 Points: Severe ventilation loss (At least one consolidation > 1 cm in diameter or subpleural consolidations > 1x2 cm in diameter) The total MLUS score will be obtained by summing the scores of the 12 regions (Minimum 0, Maximum 36). Atelectasis will be defined as "predisposition to atelectasis when each quadrant score is 2 or 3".
02

Conditions studied

  • Lung Ultrasound
  • Atelectasis

Browse trials for

Keywords

  • lung ultrasound
03

In context

Pulmonary Atelectasis

377 studies on the registry are indexed under Pulmonary Atelectasis; 93 are open to participants now.

This study's planned enrollment of 100 is above the median of 76 across 100 observational studies indexed under Pulmonary Atelectasis.

Browse Pulmonary Atelectasis studies →

Lead sponsor

Cumhuriyet University is the lead sponsor of 133 studies on the registry; 26 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

The study will include a total of 100 patients in 4 groups, aged 18-65 years, with an ASA (American Society of Anesthesiologists) physical status between I and III, who are scheduled to undergo general anesthesia in supine, prone, lateral decubitus, and lithotomy positions.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being between 18-80 years of age
  • Having status
  • Planning elective surgery under general anesthesia
  • Agreeing to participate in the study and signing the consent form

Exclusion criteria

Exclusion Criteria:

  • Patients requiring emergency surgery
  • Patients with or higher
  • Presence of a known serious preoperative lung disease (, Asthma, Pneumonia, Pleural effusion, Pneumothorax, Interstitial lung disease, Bronchiectasis, etc.)
  • History of neuromuscular disease
  • (BMI) > 35 kg/m² (Morbid obesity)
  • Presence of chest wall deformity or skin lesions that would obstruct LUS imaging
  • Cases with an operative duration of less than 60 minutes or more than 300 minutes
  • Patients with a history of thoracotomy, sternotomy, or prior open thoracic surgery
  • Patients with alcohol or drug dependence
  • Patients with significant anemia
  • Patients who are pregnant or lactating
  • Patients who develop laryngospasm following extubation
  • Refusal to provide consent or inability to cooperate
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Group 1

    Supine position

    Procedure: lung ultrasound

  • group 2

    prone position

    Procedure: lung ultrasound

  • group 3

    lateral decubitus

    Procedure: lung ultrasound

  • Group 4

    lithotomy

    Procedure: lung ultrasound

Interventions

  • Procedurelung ultrasound

    Lung Ultrasound (LUS) Protocol: The LUS evaluation will be performed by Dr. Burak Ağar using a Mindray ultrasound device \[Device brand/model and probe type, e.g., 3.5-5 MHz convex or 7-12 MHz linear probe\]

06

What researchers measure

Primary outcomes

  1. Modified Lung Ultrasound Score

    MLUS Scoring: Each region will be scored between 0-3 according to lung ventilation (MLUS Score): * 0 Points: Normal ventilation (presence of A-line, fewer than 3 B-lines) * 1 Point: Minor ventilation loss (≥ 3 B-lines or subpleural consolidations ≤ 1 cm in diameter separated by a normal pleural line) * 2 Points: Moderate ventilation loss (Multiple small subpleural consolidations ≤ 1 cm in diameter separated by multiple and converging B-lines or a thickened/irregular pleural line) * 3 Points: Severe ventilation loss (At least one consolidation \> 1 cm in diameter or subpleural consolidations \> 1x2 cm in diameter) The total MLUS score will be obtained by summing the scores of the 12 regions (Minimum 0, Maximum 36). Atelectasis will be defined as "predisposition to atelectasis when each quadrant score is 2 or 3"

    Time frame: 1. (T0):Immediately before anesthesia induction, in the supine position 2.(T1): Immediately before the patient is awakened, in the supine posit 3.(T2):Twenty minutes after the patient was admitted to the PACU (Post-Anesthesia Care Unit)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07654153
Responsible party
Oguz Gundogdu (Associate Professor, Cumhuriyet University) — Principal investigator
First posted
Jun 17, 2026
Start date
Jul 20, 2026 (estimated)
Primary completion
Jun 20, 2027 (estimated)
Completion
Aug 1, 2027 (estimated)
Last update
Jul 21, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion